SCHEMBL20122426

SCHEMBL20122426

Cc1oc(=O)oc1COC(=O)SC[C@H](NC(=O)C(C)(C)SC(=O)OCc1oc(=O)oc1C)C(=O)OC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122464 0.92 — —
SCHEMBL20122427 0.90 CYP1A2 (0.33) —
SCHEMBL20122421 0.89 — —
SCHEMBL20122564 0.89 — —
SCHEMBL20122424 0.89 CYP1A2 (0.30) —
SCHEMBL20122425 0.89 FOLH1 (0.32) —
SCHEMBL20122548 0.89 — —
SCHEMBL20122518 0.86 — —
SCHEMBL18653810 0.86 KDM4E (0.37) —
SCHEMBL20122542 0.85 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback